SKIN.L Regulatory News (SKIN)

The following amendment has been made to the 'Exercise of Warrants; Total voting rights' announcement released on 28 May 2020 at 15:30 under RNS No 2634O. The announcement now includes the expected admission date of the Warrant Shares.

All other details remain unchanged.

The full amended text is shown below.

AIM share code: SKIN

29 May 2019

Integumen PLC

("Integumen" or "Company")

Exercise of Warrants

Integumen announces that it has received notification from a warrant holder to exercise warrants over 3,000,000 shares in the share capital of Integumen ("the Warrant Shares"). The consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of £45,000.

Total voting rights

The Warrant Shares were allotted on 28 May 2020. Application has been made for the Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or about 3 June 2020. These shares will rank pari passu with the ordinary shares of the Company in issue.

The Company's total issued share capital, following the issue of the Warrant Shares, will be 1,075,416,903 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

About Integumen plc:

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.